/Companies

PD Theranostics, Inc.

New York, US · Founded 2019 · Delaware corporation · 1 known investors

Find your way into PD Theranostics, Inc.

Sign up to see every warm intro you have to PD Theranostics, Inc.

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the PD Theranostics, Inc. team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

MD
Matthew DuffyPresident, Treasurer, Secretary
PG
Patrick GallagherChief Executive Officer
JA
James AhernNamed on SEC filingGeneral Partner at Lucius Partners
MEMatthew Eitner
Matthew EitnerNamed on SEC filingGeneral Partner at Lucius Partners

Investors · 1

Reported raises · per SEC filings

Form D private placements

$508.2K disclosed across 2 rounds · 2022

▶$150KraisedDec 2023 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew EitnerDirector
  • Patrick GallagherExecutive Officer, Director
  • James AhernDirector
  • Matthew DuffyExecutive Officer, Director
Offering amount
$1M
Amount sold
$150K
Sales commissions
$15K
Proceeds to insiders
$60K
Placement agents
Laidlaw & Company (UK) Ltd.
First sale
Jul 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$358.2KraisedJul 2022 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew DuffyExecutive Officer
  • James AhernDirector
  • Patrick GallagherExecutive Officer, Director
  • Matthew EitnerDirector
Offering amount
$5.9M
Amount sold
$358.2K
Sales commissions
$43K
Proceeds to insiders
$60K
Placement agents
Laidlaw & Company (UK) Ltd.
First sale
Jul 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are PD Theranostics, Inc.'s investors?
PD Theranostics, Inc.'s investors include Lucius Partners.
How much funding has PD Theranostics, Inc. raised?
PD Theranostics, Inc. has disclosed $508.2K raised across 2 rounds.
Where is PD Theranostics, Inc. headquartered?
PD Theranostics, Inc. is headquartered in New York, US.